HMGB1 and COVID-19: For instance, high mobility group box 1 (HMGB1), which is actively secreted by necrotic cells in response to inflammatory signaling, may contribute to the hyper-inflammatory response seen in COVID-19 (Al-Kuraishy et al., 2022), leading to complications such as acute respiratory distress syndrome (ARDS) and thrombosis.